Harriet Richardson

Harriet Richardson is Associate Professor in Public Health Sciences at Queen's University, with cross-appointments at the Canadian Cancer Trials Group. Her research focuses on breast cancer prevention through clinical trials evaluating anti-estrogen therapies and their impacts on cancer incidence, mammographic density, and quality of life.

Research pillars include:

• Chemoprevention clinical trial design
• Long-term therapeutic effects monitoring
• Biomarker development for prevention
• Quality of life assessment in trials

Notable leadership includes senior authorship of the landmark NEJM paper on exemestane for breast cancer prevention. Current NIH-funded projects investigate genetic influences on treatment efficacy and menopause-related side effects.